Justices reject Johnson & Johnson appeal of $2B talc verdict

The Supreme Court is leaving in place a $2 billion verdict in favor of women who say they developed ovarian cancer from using Johnson & Johnson talc products.

Associated Press

Jun 1, 2021, 2:04 PM

Updated 1,298 days ago

Share:

The Supreme Court is leaving in place a $2 billion verdict in favor of women who say they developed ovarian cancer from using Johnson & Johnson talc products.
The justices did not comment Tuesday in rejecting Johnson & Johnson's appeal.
VACCINE INFORMATION: Check to see if you are eligible
APPOINTMENT INFORMATION: Where and how to get vaccinated
SEARCH FOR A CURE: Statistics and State Resources
The New Jersey-based company argued it was not treated fairly in facing one trial involving 22 cancer sufferers who came from 12 states and different backgrounds.
A Missouri jury initially awarded the women $4.7 billion, but a state appeals court dropped two women from the suit and reduced the award to $2 billion.
The jury found the company’s talc products contain asbestos and asbestos-laced talc can cause ovarian cancer. The company disputes both points.